FrancophonIA/ELRC3.0 huggingface dataset:
English: PACKAGE SIZE 10 pre-filled syringes 50 pre-filled syringes 100 pre-filled syringes
Icelandic: PAKKNINGASTÆRÐ 10 áfylltar sprautur 50 áfylltar sprautur 100 áfylltar sprautur
English: In a European field trial, the incidence of clinical mastitis observed in the treated group was 9.1 % (113/1235) and in the control group 12.4 % (152/1230), showing a relative reduction in mastitis incidence of 26.0 % (p=0.0094).
Icelandic: Í evrópskri vettvangsrannsókn var tíðni klínískrar júgurbólgu hjá hópnum sem fékk meðferð 9,1% (113/1.235) og í samanburðarhópnum var hún 12,4% (152/1.230), sem sýnir hlutfallslega lækkun á tíðni júgurbólgu um 26,0% (p = 0,0094).
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton and on the pre-filled syringe.
Icelandic: Ekki skal nota dýralyfið eftir fyrningardagsetningu sem tilgreind er á öskjunni og á áfylltu sprautunni.
English: Available in boxes of 10, 50 or 100 syringes.
Icelandic: Afgreitt í öskjum með 10, 50 eða 100 sprautum.
English: UK-L24 2LN
Icelandic: BRETLAND-L24 2LN
English: The active substance in Imrestor 15 mg solution for injection for cattle is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Icelandic: Virka efnið í Imrestor15 mg stungulyf, lausn fyrir nautgripi er leyft innihaldsefni samkvæmt lýsingu í töflu 1 í viðaukanum við reglugerð framkvæmdastjórnarinnar (ESB) nr. 37/2010:
English: There is no known antidote.
Icelandic: Engin mótefni eru þekkt.
English: Milk: zero days.
Icelandic: Núll dagar Mjólk:
English: Remove gloves and wash hands and exposed skin after use.
Icelandic: Eftir notkun á að fjarlægja hanska og þvo hendur og húð sem lyfið hefur komist í snertingu við.
English: During this EU study, 312 cows were treated with Imrestor for every 10 cases of clinical mastitis that were prevented during the periparturient period.
Icelandic: Evrópusambandsrannsókn stóð voru 312 kýr meðhöndlaðar með Imrestor fyrir hver 10 tilvik af klínískri júgurbólgu sem komið var í veg fyrir á tímabilinu eftir burð.
English: 50 syringes.
Icelandic: 50 sprautur.
English: Pegbovigrastim is a modified form of the naturally occurring immunoregulatory cytokine, bovine granulocyte colony stimulating factor (bG-CSF).
Icelandic: Pegbovigrastim er umbreytt mynd náttúrulega ónæmisstjórnandi cýtókínsins bG-CSF (bovine granulocyte colony stimulating factor).
English: STATEMENT OF ACTIVE SUBSTANCES Each 2.7 ml pre-filled syringe contains 15 mg pegbovigrastim.
Icelandic: VIRK(T) INNIHALDSEFNI Hver 2,7 ml áfyllt sprauta inniheldur 15 mg af pegbovigrastimi.
English: Biological/ Immunomodulat or
Icelandic: Lífefnalyf/ ónæmismótari
English: Clinical mastitis is investigated as a change in the appearance of the milk or of the quarter or of both milk and quarter.
Icelandic: Klínísk júgurbólga er metin sem breyting á útliti mjólkur eða júgurhluta eða bæði mjólkur og júgurhluta.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s) during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
Icelandic: - Mjög algengar (aukaverkanir koma fyrir hjá fleiri en 1 af hverjum 10 dýrum sem fá meðferð) - Algengar (koma fyrir hjá fleiri en 1 en færri en 10 af hverjum 100 dýrum sem fá meðferð) - Sjaldgæfar (koma fyrir hjá fleiri en 1 en færri en 10 af hverjum 1.000 dýrum sem fá meðferð) - Mjög sjaldgæfar (koma fyrir hjá fleiri en 1 en færri en 10 af hverjum 10.000 dýrum sem fá meðferð)
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2.7 ml pre-filled syringe contains:
Icelandic: Hver 2,7 ml áfyllt sprauta inniheldur:
English: No information is available with regard to a possible immune reaction towards the product or towards the endogenous molecule (bG-CSF) after repeated use of the product in cows.
Icelandic: Engar upplýsingar liggja fyrir um hugsanlega ónæmissvörun gagnvart lyfinu eða gegn eigin sameindum (bG-CSF) eftir endurtekna gjöf lyfsins hjá kúm.
English: The product should only be used on the basis of a positive benefit: risk assessment performed at the herd level by the responsible veterinarian.
Icelandic: Lyfið skal eingöngu nota á grundvelli jákvæðs mat á ætluðum ávinningi samanborið við mögulega áhættu, sem viðkomandi dýralæknir gerir á hjörðinni.
English: As expected from the mode of action of the active substance, safety data shows that a mild and transient rise in somatic cell counts in individual cows may be seen.
Icelandic: Eins og vænta má vegna verkunarmáta virka efnisins sýna upplýsingar um öryggi þess að hjá sumum kúm getur komið fram smávægileg og tímabundin hækkun frumutölu.
English: bG-CSF presents additional functions beyond its action on neutrophils and these may be direct or indirect functions on other cells/receptors and cytokine pathways.
Icelandic: bG-CSF veitir viðbótarvirkni umfram verkun á daufkyrninga og getur hún, beint eða óbeint, verið verkun á aðrar frumur/viðtaka og boðferla cýtókína.
English: NO ENTRY
Icelandic: ENGIN FÆRSLA
English: A. MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs
Icelandic: FRAMLEIÐENDUR SEM ERU ÁBYRGIR FYRIR LOKASAMÞYKKT B. FORSENDUR FYRIR EÐA TAKMARKANIR Á AFGREIÐSLU OG NOTKUN C. UPPLÝSINGAR
English: 100 syringes.
Icelandic: 100 sprautur.
English: STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) The product is a clear, colourless to pale yellow solution for injection containing 15 mg pegbovigrastim (pegylated bovine colony stimulating factor) in a pre-filled syringe.
Icelandic: INNIHALDSEFNI OG ÖNNUR INNIHALDSEFNI Lyfið er tært, litlaust eða fölgult stungulyf, lausn sem inniheldur 15 mg af pegbovigrastimi (pegýleruðu nautgripa G-CSF (Granulocyte Colony Stimulating
English: 10 syringes.
Icelandic: 10 sprautur.
English: Cattle (dairy cows and heifers).
Icelandic: Nautgripir (mjólkurkýr og kvígur).
English: Symptomatic treatment may be required.
Icelandic: Meðferð í samræmi við einkenni getur verið nauðsynleg.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cartons of 10, 50 or 100 syringes
Icelandic: SEM EIGA AÐ KOMA FRAM Á YTRI UMBÚÐUM Öskjur með 10, 50 eða 100 sprautum
English: The syringes are packed into cardboard boxes as follows;
Icelandic: Sprautunum er pakkað með eftirfarandi hætti í pappaöskjur:
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Icelandic: Lyfjastofnunar Evrópu http://www.ema.europa.eu/ (Upplýsingar á íslensku eru á http://www.serlyfjaskra.is).
English: In animals, which have pharmaceutically altered immune function e.g. those which have recently received systemically administered corticosteroids or non-steroidal anti-inflammatory drugs the product may not be effective.
Icelandic: Hjá dýrum þar sem starfsemi ónæmiskerfisins er breytt af völdum lyfja, t.d. hjá dýrum sem nýlega hafa verið gefnir barksterar eða bólgueyðandi verkjalyf, getur verið að lyfið virki ekki sem skyldi.
English: Subcutaneous administration of the product may induce transient local swelling at the injection site as well as inflammatory reactions which resolve within 14 days post treatment.
Icelandic: Gjöf lyfsins undir húð getur orðið til þess að tímabundinn þroti komi fram á stungustað, ásamt bólguviðbrögðum sem hverfa innan 14 daga eftir meðferð.
English: Do not mix with any other veterinary medicinal products.
Icelandic: Ekki má blanda þessu dýralyfi saman við nein önnur dýralyf.
English: Bovine No MRL required
Icelandic: Engin krafa um MRL
English: 2.7 ml of solution for injection in a pre-filled polypropylene colourless syringe with siliconised chlorobutyl stopper and a stainless steel needle with needle guard.
Icelandic: 2,7 ml af stungulyfi, lausn í áfylltri, litlausri pólýpropýlensprautu með sílikonhúðuðum klóróbútýltappa og nál úr ryðfríu stáli með nálarhettu.
English: There may also be other effects including nausea and a skin rash, hypersensitivity reactions (breathing difficulties, hypotension, urticaria and angioedema).
Icelandic: Einnig geta önnur áhrif komið fram, t.d.. ógleði, útbrot, ofnæmisviðbrögð (öndunarerfiðleikar, lágþrýstingur, ofsakláði og ofsabjúgur).
English: There is no information about the pharmacokinetics of pegbovigrastim in cattle.
Icelandic: Engar upplýsingar liggja fyrir um lyfjahvörf pegbovigrastims hjá nautgripum.
English: People with known hypersensitivity to pegbovigrastim should avoid contact with the product.
Icelandic: Þeir sem hafa ofnæmi fyrir pegbovigrastimi skulu forðast snertingu við dýralyfið.
English: Seek medical advice immediately and show the package leaflet or the label to the physician.
Icelandic: Leitið tafarlaust læknis og hafið meðferðis fylgiseðil eða umbúðir dýralyfsins.
English: Based on all field studies, the proportion of mastitis prevented due to herd treatment with Imrestor (Prevented Fraction) is 0.25 (with 95% confidence interval 0.14 - 0.35).
Icelandic: öllum vettvangsrannsóknum er hlutfall júgurbólgu sem komið var í veg fyrir með því að meðhöndla hjörðina með Imrestor (hindrunarhlutfall) 0,25 (með 95% öryggisbili 0,14 - 0,35).
English: Excessive shaking of the syringe may aggregate pegbovigrastim, reducing its biological activity.
Icelandic: Ef sprautan er hrist of mikið getur það valdið því að pegbovigrastim kekkist, sem dregur úr líffræðilegri virkni þess.
English: Pegylated bovine granulocyte colony stimulating factor
Icelandic: Þættir til örvunar (colony stimulating factors).
English: Treatment should be symptomatic.
Icelandic: Meðferð skal að vera í samræmi við einkenni.
English: Only clear solutions without particles should be used.
Icelandic: Aðeins skal nota tæra lausn án agna.
English: Evidence from similar active substances in humans suggests that accidental administration of more than the authorised dose could result in adverse reactions, which are related to the activity of pegbovigrastim.
Icelandic: Gögn um sambærileg virk efni hjá mönnum benda til þess að ef fyrir slysni er gefið meira en ráðlagður skammtur af lyfinu geti það leitt til aukaverkana sem tengjast virkni pegbovigrastims.
English: The content of a second pre-filled syringe is to be injected subcutaneously within 24 hours after calving.
Icelandic: Sprauta skal innihaldi annarrar áfylltrar sprautu undir húð innan 24 klst. eftir burð.
English: In the case of accidental self -injection, headache, bone and muscle pain may occur.
Icelandic: Ef sá sem annast lyfjagjöf gefur sjálfum sér dýralyfið fyrir slysni getur komið fram bein-, vöðva- og höfuðverkur.
English: These clinical signs typically appear between 30 minutes and 2 hours after the first dose and resolve within 2 hours.
Icelandic: Þessi klínísku einkenni komu að jafnaði fram frá 30 mín. til 2 klst.
English: No information is available on the safety and efficacy of the concurrent use of this product with vaccines.
Icelandic: Engar upplýsingar liggja fyrir um öryggi eða verkun þessa lyfs þegar það er notað samhliða bóluefnum.
English: Concurrent administration of substances which alter immune function (e.g. corticosteroids or non steroidal anti-inflammatory drugs) may reduce the efficacy of the product.
Icelandic: Samhliða notkun lyfja sem breyta starfsemi ónæmiskerfisins (s.s. barkstera eða bólgueyðandi verkjalyfja) getur dregið úr virkni lyfsins.
English: In one safety study in Jersey cows the margin of safety of this product was 1.5x the highest recommended dose (an overdose of 60µg/kg was administered on three occasions) (see also section 4.10).
Icelandic: Í einni rannsókn á öryggi lyfsins hjá kúm af Jersey-kyni voru öryggismörk lyfsins 1,5 x hæsti ráðlagði skammtur (of stór skammtur sem nam 60 µg/kg var gefinn í þremur tilfellum) (sjá einnig kafla 4.10).
English: United Kingdom
Icelandic: Bretland eða
English: In the clinical studies, non-typical anaphylactoid reactions were uncommonly observed.
Icelandic: Í klínískum rannsóknum voru ódæmigerð bráðaofnæmisviðbrögð sjaldgæf.
English: Concurrent use of such products should be avoided.
Icelandic: Forðast skal samhliða notkun slíkra lyfja.
English: Colony stimulating factors regulate the production and functional activities of immune cells.
Icelandic: Örvunarþættir stjórna myndun og virkni ónæmisfrumna.
English: The content of a single pre-filled syringe is to be injected subcutaneously to a dairy cow/heifer 7 days before the anticipated date of calving.
Icelandic: Sprauta skal innihaldi einnar áfylltrar sprautu undir húð hjá mjólkurkú/kvígu 7 sólarhringum fyrir áætlaðan burð.
English: Or
Icelandic: Samkvæmt
English: Do not exceed the stated dose.
Icelandic: Ekki gefa meira en ráðlagðan skammt.
English: Personal protective equipment consisting of gloves should be worn when handling broken or damaged syringes.
Icelandic: Nota skal hlífðarhanska þegar brotnar eða skemmdar sprautur eru handleiknar.
English: CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Icelandic: Gefið ekki dýrum sem hafa ofnæmi fyrir virka efninu eða einhverju hjálparefnanna.
English: In one safety study in Jersey cows, at overdose of 60 µg/kg, administered on three occasions (1.5x the highest recommended dose), abomasal ulcers were observed.
Icelandic: Í einni rannsókn á öryggi lyfsins hjá kúm af Jersey-kyni sem voru gefnir þrír of stórir skammtar, sem námu 60 µg/kg (1,5 x stærsti ráðlagði skammtur), leiddi í ljós sár í vinstur.
English: Meat and offal: zero days.
Icelandic: Kjöt og innmatur:
English: TARGET SPECIES Cattle (dairy cows and heifers)
Icelandic: DÝRATEGUND(IR) Nautgripir (mjólkurkýr og kvígur)
English: It has also been proved that it enhances myeloperoxidase hydrogen peroxide halide mediated microbiocidal capabilities of neutrophils.
Icelandic: Einnig hefur verið sýnt fram á að það eykur getu daufkyrninga til að drepa örverur, sem miðlað er með efnahvarfi vetnisperoxíðs og halíða, fyrir tilstilli mýelóperoxíðasa.
English: In one safety study in Jersey cows the margin of safety of this product was 1.5x the highest recommended dose (an overdose of 60µg/kg was administered on three occasions).
Icelandic: Í einni rannsókn á öryggi lyfsins hjá kúm af Jersey-kyni voru öryggismörk lyfsins 1,5 x hæsti ráðlagði skammtur (of stór skammtur sem nam 60 µg/kg var gefinn í þremur tilfellum).
English: DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.
Icelandic: Lyfjastofnunar Evrópu http://www.ema.europa.eu/ Upplýsingar á íslensku eru á http://www.serlyfjaskra.is.
English: The immunoregulatory activities of granulocyte colony stimulating factor concerns notably cells of the neutrophilic granulocyte lineage which bear cell surface receptors for the protein.
Icelandic: Áhrif bG-CSF til stjórnunar ónæmiskerfisins varða einkum daufkyrninga sem eru með yfirborðsviðtaka fyrir próteinið.
English: The efficacy was tested alongside normal dairy herd management practices.
Icelandic: Verkunin var prófuð samhliða hefðbundnum starfsháttum um heilbrigðisáætlun hjarða með mjólkurkúm.
English: As an aid in a herd management programme, to reduce the risk of clinical mastitis in periparturient dairy cows and heifers during the 30 days following calving.
Icelandic: Til notkunar handa mjólkurkúm og kvígum á tímabilinu fyrir og eftir burð, sem liður í heilbrigðisáætlun innan hjarðar til að draga úr hættu á klínískri júgurbólgu fyrstu 30 dagana eftir burð.
English: If you notice any serious effects or other effects not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Icelandic: Gerið dýralækni viðvart ef vart verður einhverra aukaverkana, jafnvel aukaverkana sem ekki eru tilgreindar í fylgiseðlinum eða ef svo virðist sem lyfið hafi ekki tilætluð áhrif.
English: The cows presented with swelling of mucous membranes (notably vulva and eyelid), skin reactions, increased respiration rate and salivation.
Icelandic: Kýrnar fengu slímhimnubólgu (einkum í sköp og á augnlok).
English: Pegbovigrastim (Pegylated bovine Granulocyte Colony Stimulating Factor [PEG bG-CSF]) 15 mg For the full list of excipients, see section 6.1.
Icelandic: Pegbovigrastim (pegýlerað nautgripa G-CSF (Granulocyte Colony Stimulating Factor) [PEG bGCSF])
English: Bovine granulocyte colony stimulating factor is a naturally occurring protein produced by mononuclear leukocytes, endothelial cells and fibroblasts.
Icelandic: bG-CSF er náttúrulegt prótein sem einkjarna hvítfrumur, þekjufrumur og trefjakímfrumur mynda.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Imrestor 15 mg solution for injection for cattle
Icelandic: HEITI DÝRALYFS Imrestor 15 mg stungulyf, lausn fyrir nautgripi
English: PACKAGE LEAFLET Imrestor 15 mg solution for injection for cattle
Icelandic: Imrestor 15 mg stungulyf, lausn fyrir nautgripi
English: ATCvet code: QL03AA90
Icelandic: QL03AA90.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Imrestor 15 mg solution for injection for cattle pegbovigrastim
Icelandic: Imrestor 15 mg stungulyf, lausn fyrir nautgripi pegbovigrastim
English: The product increases the number of circulating neutrophils.
Icelandic: Lyfið fjölgar daufkyrningum í blóðrásinni.
English: 4.7 Use during pregnancy and lactation
Icelandic: 4.7 Notkun á meðgöngu, við mjólkurgjöf og varp
English: Only for subcutaneous administration.
Icelandic: Eingöngu til notkunar undir húð.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS 2.7 ml pre-filled syringe
Icelandic: INNRI UMBÚÐUM 2,7 ml áfylltar sprautur
English: Only for subcutaneous injection.
Icelandic: LYFJAFORM Stungulyf, lausn.
English: Shelf -life after first opening the immediate packaging: use immediately.
Icelandic: Geymsluþol eftir að innri umbúðir hafa verið rofnar:
English: This leaflet was last revised in {MM/YYYY} .
Icelandic: Þessi fylgiseðill var síðast uppfærður í {MM/ÁÁÁÁ}.
English: Marketing Authorisation Holder and Manufacturers:
Icelandic: Markaðsleyfishafi og framleiðendur:
English: Very rare,
Icelandic: Mjög sjaldgæfar
English: Clopidogrel Apotex with food and drink Clopidogrel Apotex may be taken with or without food.
Icelandic: Notkun Clopidogrel Apotex með mat eða drykk Clopidogrel Apotex má taka með eða án matar.
English: You should take Clopidogrel Apotex for as long as your doctor continues to prescribe it.
Icelandic: Þú skalt taka Clopidogrel Apotex meðan læknirinn heldur áfram að ávísa því.
English: Some other medicines may influence the use of Clopidogrel Apotex or vice versa.
Icelandic: Sum önnur lyf geta haft áhrif á notkun Clopidogrel Apotex og öfugt.
English: In addition, your doctor may identify changes in your blood or urine test results.
Icelandic: Að auki gæti læknirinn greint breytingar á niðurstöðum blóð- eða þvagprófa.
English: Platelets are very small structures in the blood which clump together during blood clotting.
Icelandic: Blóðflögur eru mjög smáar agnir í blóðinu sem festast saman þegar blóð storknar.
English: If you forget to take a dose of Clopidogrel Apotex, but remember within 12 hours of your usual time, take your tablet straightaway and then take your next tablet at the usual time.
Icelandic: Ef þú gleymir að taka Clopidogrel Apotex skammt, en manst eftir því innan 12 klst. frá venjulegum inntökutíma, skaltu taka töfluna strax og síðan næstu töflu á venjulegum tíma.
English: Excipients with a known effect:
Icelandic: Hjálparefni með þekkta verkun:
English: Pharmathen S.A. 6, Dervenakion 15351 Pallini Attiki Greece
Icelandic: Pharmathen S.A. 6, Dervenakion 15351 Pallini Attiki Grikkland
English: repaglinide, medicine to treat diabetes, paclitaxel, medicine to treat cancer.
Icelandic: repaglíníð, lyf við sykursýki, paclitaxel, lyf við krabbameini.
English: anti-retroviral medicines (medicines to treat HIV infections).
Icelandic: veirulyf gegn retróveirum (lyf til meðferðar á HIV-sýkingum)
English: The most common side effect reported with Clopidogrel Apotex is bleeding.
Icelandic: Algengasta aukaverkunin sem tilkynnt hefur verið um vegna Clopidogrel Apotex er blæðing.
English: Hypromellose (E464) Lactose monohydrate Triacetin (E1518) Titanium dioxide (E171) Red iron oxide (E172)
Icelandic: Hýprómellósi (E464) Laktósaeinhýdrat Tríacetín (E1518) Títantvíoxíð (E171) Rautt járnoxíð (E172)
English: Date of first authorisation: 16.10.2009 Date of latest renewal: 18.09.2014
Icelandic: 16.10.2009 Nýjasta dagsetning endurnýjunar markaðsleyfis:
English: Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/
Icelandic: Ítarlegar upplýsingar um lyfið eru birtar á vef Lyfjastofnunar Evrópu http://www.ema.europa.eu/.
English: The active metabolite is formed mostly by CYP2C19 with contributions from several other CYP enzymes, including CYP1A2 CYP2B6 and CYP3A4.
Icelandic: Virka umbrotsefnið er aðallega myndað af CYP2C19 með hjálp nokkurra annarra CYP ensíma, þar á meðal CYP1A2, CYP2B6 og CYP3A4.
English: However, if you are concerned by your bleeding, you should contact your doctor straightaway (see section 2 ‘Warnings and precautions').
Icelandic: Ef þú hefur hins vegar áhyggjur af blæðingunni skalt þú strax hafa samband við lækninn (sjá kafla 2 „Varnaðarorð og varúðarreglur“).
English: If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopidogrel Apotex (4 tablets of 75 mg) once at the start of treatment.
Icelandic: Ef þú hefur fundið fyrir verulegum verk fyrir brjósti (hvikul hjartaöng eða hjartaáfall) getur verið að læknirinn gefi þér 300 mg af Clopidogrel Apotex (fjórar 75 mg töflur) í eitt skipti við upphaf meðferðar.
English: Your doctor should have prescribed Clopidogrel plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding.
Icelandic: Læknirinn ætti að hafa ávísað þér Clopidogrel Apotex og acetýlsalicýlsýru ef þú getur ekki tekið blóðþynningarlyf og ef þú ert ekki í hættu á að fá miklar blæðingar.
English: Pharmathen S.A., 6 Dervenakion 15351 Pallini Attiki Greece
Icelandic: Pharmathen S.A., 6 Dervenakion 15351 Pallini Attiki Grikkland eða
English: Medicinal products that are strong or moderate CYP2C19 inhibitors include for example omeprazole and esomeprazole, fluvoxamine, fluoxetine, moclobemide, voriconazole, fluconazole, ticlopidine, carbamazepine, and efavirenz.
Icelandic: Lyf sem eru öflugir eða í meðallagi öflugir hemlar á CYP2C19 eru t.d. omeprazol og esomeprazol, fluvoxamin, fluoxetin, moclobemid, voriconazol, fluconazol, ticlopidin, carbameazepin og efavirenz.
English: TROPICAL-ACS (Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes)
Icelandic: Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes)
English: If HPR≥46 units, the patients were escalated back to prasugrel 5 or 10 mg/d for 11.5 months; if HPR<46 units, the patients continued on clopidogrel 75 mg/d for 11.5 months.
Icelandic: 46 einingar var sjúklingnum aftur látinn fá prasugrel 5 eða 10 mg/sólarhring í 11,5 mánuði; ef HPR var < 46 einingar hélt sjúklingurinn áfram á klópídógreli 75 mg/sólarhring í 11,5 mánuði.
English: Clopidogrel Apotex film-coated tablets are pink, round and biconvex.
Icelandic: Clopidogrel Apotex filmuhúðaðar töflur eru bleikar, kringlóttar og tvíkúptar.
English: As a precautionary measure, breast-feeding should not be continued during treatment with Clopidogrel Apotex.
Icelandic: Sem varúðarráðstöfun á ekki að halda áfram brjóstagjöf meðan á Clopidogrel Apotex meðferð stendur.
English: Clopidogrel has been tested in a range of in vitro and in vivo genotoxicity studies,and showed no genotoxic activity.
Icelandic: Klópídógrel hefur verið prófað í margvíslegum in vitro og in vivo rannsóknum á eituráhrifum á erfðaefni og sýndi engin eituráhrif.